Genomma Lab Intl Sab Ord

Greetings, ladies and gentlemen. Thank you for standing by. Welcome to the Genoma Lab second quarter 2022 results conference call. At this time, all participants are in a listen-only mode. We will conduct a question and answer session following today's discussion. Instructions will be provided at that time for you to queue up for questions. A replay will also be available shortly after the conclusion of the call. I'll now turn the call over to Barbara Cano of the INSPIRE group. Please go ahead.

Thank you and good morning, everyone. I want to thank you for listening to our remarks for Genoma's second quarter 2022 earnings. Joining me today are Jorge Breg, Chief Executive Officer, and Antonio Zamora, Chief Financial Officer. Before I hand our call over, let me first touch on a few items. On Genoma's website, you will find our press release that was posted yesterday after markets closed. Please note that today's remarks include forward-looking statements that are based on management's current views and assumptions. While management believes that its assumptions, expectations, and projections are reasonable in the view of the currently available information, you are cautioned not to place undue reliance on these forward-looking statements and to carefully review all documents filed by Genoma with a Mexican bolsa. Let me now turn the call over to Mr. Jorge Briggs.

Jorge?